Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03517007 · ClinicalTrials.gov registry record · NA
The DETOURS Trial: De-escalating Empiric Treatment: Opting Out of Rx for Selected Patients With Suspected Sepsis - Opt-Out Protocol Trial
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 762
- Enrollment target
NCT03517007 is a NA study that has completed, run by Duke University. The registered enrollment target is 762 participants.
The verdict
NCT03517007, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 762 participants
- Enrollment target
Study Summary
The objective of this study is to implement an opt-out protocol to guide appropriate de-escalation of antibiotics in qualifying patients. The protocol, determined over the course a year with the help of a large, well-rounded expert panel, will be used by pharmacists to recommend de-escalation of antibiotics to hospital providers. Providers can then decide whether or not to follow the recommendation in determining the best treatment pathway for his or her patient.
Interventions
- OTHER Opt-Out Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 762 participants |
| Start Date | 2018-09-12 |
| Est. Completion | 2020-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03517007
The ClinicalTrials.gov registry entry for NCT03517007 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 762 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Opt-Out Protocol is the first listed.
NCT03517007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03517007 about?
NCT03517007 is a clinical study titled "The DETOURS Trial: De-escalating Empiric Treatment: Opting Out of Rx for Selected Patients With Suspected Sepsis - Opt-Out Protocol Trial". The objective of this study is to implement an opt-out protocol to guide appropriate de-escalation of antibiotics in qualifying patients. The protocol, determined over the course a year with the help of a large, well-rounded expert panel, will be used by pharmacists to recommend de-escalation of ant...
What is the current status of trial NCT03517007?
This trial is currently completed. It is a NA study. The enrollment target is 762 participants. The study started on 2018-09-12. Estimated completion is 2020-08-10.
What interventions are being tested in trial NCT03517007?
The interventions under investigation include: Opt-Out Protocol (OTHER).
Who is sponsoring clinical trial NCT03517007?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.